価格表

在庫・価格 : 2024年05月07日 19時31分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
IL-32α, Human, Recombinant, Carrier-free
データシート
3040-IL-050 RSDアールアンドディー システムス
R&D Systems, Inc.
50 μg ¥90,000
(未発注)
追加

在庫・価格 : 2024年05月07日 19時31分 現在

IL-32α, Human, Recombinant, Carrier-free

  • 商品コード:3040-IL-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥90,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Heinhuis B et al. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 2011 Mar;108(12):4962-7
Heinhuis B et al
2011/01/01
Application: ELISA Standard, Sample Type: N/A PubMed
2 Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
Wilson TR et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Wong CK et al. Molecular mechanisms regulating the synergism between IL-32γ and NOD for the activation of eosinophils. J. Leukoc. Biol. 2014 Apr;95(4):631-42
Wong CK et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
4 Osman A et al. M-CSF inhibits anti-HIV-1 activity of IL-32, but they enhance M2-like phenotypes of macrophages. J. Immunol. 2014 Jun;192(11):5083-9
Osman A et al
2014/01/01
Application: Bioassay, Sample Type: blood (heparin) PubMed
5 Taube JM et al. Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade. Clin. Cancer Res. 2015 Sep;21(17):3969-76
Taube JM et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
6 Gorvel L et al. Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function. J. Immunol. 2017 Aug;199(4):1290-1300
Gorvel L et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Heinhuis B et al. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 2011 Mar;108(12):4962-7
    Heinhuis B et al
    2011/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
    Wilson TR et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wong CK et al. Molecular mechanisms regulating the synergism between IL-32γ and NOD for the activation of eosinophils. J. Leukoc. Biol. 2014 Apr;95(4):631-42
    Wong CK et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Osman A et al. M-CSF inhibits anti-HIV-1 activity of IL-32, but they enhance M2-like phenotypes of macrophages. J. Immunol. 2014 Jun;192(11):5083-9
    Osman A et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: blood (heparin)
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Taube JM et al. Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade. Clin. Cancer Res. 2015 Sep;21(17):3969-76
    Taube JM et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Gorvel L et al. Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function. J. Immunol. 2017 Aug;199(4):1290-1300
    Gorvel L et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed